In 2023, 19,375,681 doses of vaccines were applied, of which 55.5% were for the population between 10 and 19 years old and over 20 years old; 16.2% for the population under one year old; 8.7% for the 4 and 6 year old population; 7.2% for the 18-month-old population; 7.0% for the newborn population, and 5.4% for the 1-year-old population.
However, Censia did not design, update, or implement permanent in-person or remote training courses for health personnel already incorporated and new to the Vaccination Program.
Furthermore, it did not quantify the estimated target population, by federal entity, for the age groups of newborns; under one year old; one year; 18 months; four years, and six years, nor to the population that was served, through the application of the 8,614,576 doses of the BCG, Anti-Hepatitis B, Hexavalent acellular, Anti-Pneumococcal conjugate, Anti-rotavirus, Anti-Influenza, SRP and DPT.
Nor did it quantify the estimated target population, by federal entity, for the age groups of 10 to 19 years and adults from 20 years of age, nor the population that was served, through the application of the 10,761,105 doses of the TD, SRP, Hepatitis B 20mcg, HPV, TDPA, Anti-Influenza, Pneumococcal conjugate and Anti-pneumococcal polysaccharide vaccines.
